Get the Stockscreener App
0.6769
20.83%
0.1167
Applied Therapeutics Inc stock is traded at $0.6769, with a volume of 11.45M.
It is up +20.83% in the last 24 hours and up +26.88% over the past month.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
See More
Previous Close:
$0.5602
Open:
$0.5746
24h Volume:
11.45M
Relative Volume:
7.30
Market Cap:
$97.44M
Revenue:
-
Net Income/Loss:
$-119.76M
P/E Ratio:
-0.5014
EPS:
-1.35
Net Cash Flow:
$-55.17M
1W Performance:
+55.72%
1M Performance:
+26.88%
6M Performance:
+29.35%
1Y Performance:
-91.95%
1-Day Range:
$0.5602
$0.7657
1-Week Range:
$0.4356
$0.7657
52-Week Range:
$0.295
$10.62
Applied Therapeutics Inc Stock (APLT) Company Profile
Name
Applied Therapeutics Inc
Sector
Industry
Phone
212-220-9226
Address
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Compare APLT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APLT
Applied Therapeutics Inc
|
0.6766 | 80.68M | 0 | -119.76M | -55.17M | -1.35 |
|
VRTX
Vertex Pharmaceuticals Inc
|
385.22 | 97.91B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
444.28 | 58.93B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
553.42 | 58.88B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
716.78 | 43.52B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
325.31 | 36.11B | 3.81B | -644.79M | -669.77M | -6.24 |
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-23-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-02-24 | Downgrade | UBS | Buy → Neutral |
| Nov-29-24 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Jul-31-24 | Initiated | William Blair | Outperform |
| Mar-26-24 | Initiated | RBC Capital Mkts | Outperform |
| Feb-22-24 | Initiated | Leerink Partners | Outperform |
| Jan-04-22 | Downgrade | Barclays | Overweight → Equal Weight |
| Aug-27-21 | Downgrade | Goldman | Neutral → Sell |
| Jun-25-21 | Resumed | Goldman | Neutral |
| Oct-08-20 | Initiated | Truist | Buy |
| Apr-22-20 | Initiated | Goldman | Buy |
| Feb-27-20 | Initiated | Barclays | Overweight |
| Jun-10-19 | Initiated | Citigroup | Buy |
| Jun-10-19 | Initiated | Cowen | Outperform |
| Jun-10-19 | Initiated | Robert W. Baird | Outperform |
View All
Applied Therapeutics Inc Stock (APLT) Latest News
Why retail investors favor Applied Therapeutics Inc. stockPortfolio Return Summary & Expert Approved Trade Ideas - newser.com
Is Applied Therapeutics Inc. stock near bottom after declineEarnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
How Applied Therapeutics Inc. stock compares to industry benchmarksInflation Watch & Real-Time Chart Pattern Alerts - newser.com
Will Applied Therapeutics Inc. stock benefit from automationMarket Movement Recap & AI Forecasted Entry and Exit Points - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Applied Therapeutics ($APLT) Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView
Detecting price anomalies in Applied Therapeutics Inc. with AIMarket Growth Report & Breakout Confirmation Trade Signals - newser.com
When is the best time to exit Applied Therapeutics Inc.Market Risk Analysis & Weekly High Potential Alerts - newser.com
Is Applied Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Why Applied Therapeutics Inc. is moving today2025 EndofYear Setup & Community Consensus Stock Picks - newser.com
Will Applied Therapeutics Inc. continue its uptrendTrade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Applied Therapeutics Agrees to Pay Settlement to $APLT Investors — Here’s How to Get Your Share - TradingView
Automated trading signals detected on Applied Therapeutics Inc.July 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Will Applied Therapeutics Inc. see short term momentumEarnings Performance Report & Free AI Powered Buy and Sell Recommendations - newser.com
2025-09-21 | Bronstein, Gewirtz & Grossman, LLC Encourages Applied Therapeutics, Inc. (APLT) Stockholders to Inquire about Securities Investigation | NDAQ:APLT | Press Release - Stockhouse
Analysts Set Applied Therapeutics Inc. (NASDAQ:APLT) Target Price at $6.10 - MarketBeat
What MACD and RSI say about Applied Therapeutics Inc.Insider Selling & Stock Portfolio Risk Management - newser.com
Multi factor analysis applied to Applied Therapeutics Inc.July 2025 Breakouts & Long Hold Capital Preservation Plans - newser.com
Custom strategy builders for tracking Applied Therapeutics Inc.Risk Management & Stepwise Trade Signal Implementation - newser.com
What to expect from Applied Therapeutics Inc. in the next 30 daysJuly 2025 Setups & Risk Managed Investment Signals - newser.com
Predicting Applied Therapeutics Inc. trend using moving averages2025 Earnings Impact & Safe Capital Allocation Plans - newser.com
How to recover losses in Applied Therapeutics Inc. stockRate Hike & Low Drawdown Investment Strategies - newser.com
What moving averages say about Applied Therapeutics Inc.July 2025 PreEarnings & Community Shared Stock Ideas - newser.com
Signal strength of Applied Therapeutics Inc. stock in tech scannersMarket Activity Report & Technical Pattern Based Signals - newser.com
Evaluating Applied Therapeutics Inc. with trendline analysis2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Advanced analytics toolkit walkthrough for Applied Therapeutics Inc.2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Applied Therapeutics Inc backed by strong institutional buyingWeekly Trade Report & Weekly Momentum Picks - khodrobank.com
Applied Therapeutics Inc. (NASDAQ:APLT) Receives $6.10 Average Target Price from Analysts - Defense World
Quarterly Recap: Can Applied Therapeutics Inc keep up with sector leadersPortfolio Performance Report & Daily Technical Stock Forecast Reports - خودرو بانک
Important Notice to Long-Term Shareholders of Applied Therapeutics, Inc. (NASDAQ: APLT); DoubleVerify Holdings, Inc. (NYSE: DV); Elevance Health Inc. (NYSE: ELV); and V.F. Corp. (NYSE: VFC): Grabar Law Office is Investigating Claims on Your Behalf - GlobeNewswire Inc.
Applied Therapeutics Announces New Equity Offering Agreement - MSN
How moving averages guide Applied Therapeutics Inc. tradingMarket Sentiment Review & Safe Capital Preservation Plans - newser.com
Wall Street Recap: Can Applied Therapeutics Inc continue delivering strong returnsJuly 2025 Analyst Calls & Risk Controlled Swing Alerts - خودرو بانک
Bronstein, Gewirtz & Grossman, LLC Is Investigating Applied Therapeutics, Inc. (APLT) And Encourages Stockholders to Connect - ACCESS Newswire
Important Notice to Long-Term Shareholders of Applied - GlobeNewswire
Smart Money: Can Applied Therapeutics Inc continue delivering strong returnsWall Street Watch & Pattern Based Trade Signal System - خودرو بانک
Can Applied Therapeutics Inc maintain sales growthMarket Growth Summary & Daily Stock Trend Reports - خودرو بانک
Market Trends: Can Applied Therapeutics Inc continue delivering strong returns2025 Growth vs Value & Daily Market Momentum Tracking - خودرو بانک
Quarterly Risk: What is Applied Therapeutics Incs valuation compared to sectorQuarterly Performance Summary & Real-Time Chart Pattern Alerts - خودرو بانک
Trading Recap: Is Applied Therapeutics Inc. in a bullish channelTrade Entry Summary & Fast Momentum Entry Tips - خودرو بانک
Portfolio Shifts: Is RNGR stock technically oversoldJuly 2025 Market Mood & Daily Entry Point Alerts - khodrobank.com
Update Report: Does Applied Therapeutics Inc. have strong fundamentals2025 Market Overview & AI Driven Price Predictions - خودرو بانک
Fed Watch: Will Applied Therapeutics Inc. benefit from sector rotationDay Trade & Safe Capital Growth Plans - خودرو بانک
Silicon Valley - FinancialContent
Applied Therapeutics Inc Stock (APLT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Applied Therapeutics Inc Stock (APLT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Funtleyder Leslie D. | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
14,502 |
6,381 |
390,459 |
| Chinoporos Constantine | See Remarks |
Mar 04 '25 |
Sale |
0.44 |
447 |
197 |
271,436 |
| Funtleyder Leslie D. | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
22,950 |
14,000 |
404,961 |
| Perfetti Riccardo | Chief Medical Officer |
Feb 06 '25 |
Sale |
0.61 |
86,078 |
52,508 |
900,775 |
| Chinoporos Constantine | See Remarks |
Feb 06 '25 |
Sale |
0.61 |
28,117 |
17,151 |
271,883 |
0.59%
0.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):